For the 2020 cohort of the program, we will be looking to receive proposals from applicants in relation to one of the three following challenges:
Deadline for Submission:
09/12/2020 at 20:00 (Israel Time Zone)
StarFinder is an exclusive innovation program for entrepreneurs to execute ‘Proof of Concept’ (POC) digital health projects based on validated Healthcare market needs. Established in 2020 by Roche and aMoon Fund, this unique early stage program is aimed at identifying exceptional Israeli entrepreneurs who are addressing pressing global health challenges.
Selected entrepreneurs will receive funding to develop their “Proof of Concept” based on data from Israeli HMOs and/or hospitals, mentoring, unparalleled access to leading global expertise from within Roche and aMoon, personal office space at aMoon’s offices, and more. StarFinder Lab will launch one cohort per year, each cohort will be made of 3 elected ventures centered each around a specific challenge.
Applicants must be either: (i) Israeli entrepreneurs (ii) Israeli researchers / practicing professionals in an academic institution or a healthcare organization or (iii) a registered and operating company in Israel (“Existing Company”). In the case of (i) or (ii) above, a designated company registered and operating in Israel will need to be incorporated ahead of commencing the program. In the case of (iii) above, the Existing Company or the shareholders thereof may be required to incorporate a new company, registered and operating in Israel, designated to participate in the program.
The proposed project will be evaluated based on a variety of parameters, including (but not limited to): quality and strength of the team; potential for market disruption; innovation excellence; technological feasibility to reach a POC within 9 months and the allotted budget, relying on the use of data and AI; value to patients and healthcare (outcomes and costs).
Each venture will receive $125K from each of aMoon and Roche under a certain funding framework.
The application process has five phases:
First Phase – by [9/12/2020]: submission of applications through StarFinder website
Second Phase – by [6-7/1/2021]:first round pitch for shortlisted companies
Third Phase – by [20-21/1/2021]: second round pitch for pre-selected companies
Fourth Phase – by [28/1/2021]: pre – announcement for cohort 1 companies
Fifth Phase – by [18/2/2021]: execution of definitive documents
Please read carefully all the terms and conditions of this call for proposals before submitting an application. Submission of applications in response to this call for proposals are made under the sole responsibility of the applicants and at their own risk.
It is strongly advised to apply sufficiently in advance of the deadline for submission. For the avoidance of doubt, it is clarified that no applications will be accepted after the deadline for submission.
We reserve the right, at any time at our sole discretion: (i) to change or cancel this call for proposals or any of the terms thereof, (ii) to change, suspend or cancel the program or the challenges. Any changes or notices with respect to suspension or cancellation will be published on the website. Applicants are advised to regularly check the website. By applying to the program each applicant gives its consent to such changes, suspension or cancellation in advance. Such changes, suspension or cancellation are without entitlement to compensation. you acknowledge and confirm that you are aware that we define the challenges at our sole discretion.
By applying to the Program you confirm that you lawfully own all Intellectual Property Rights (“IPRs”) included in your application and that to the best of your knowledge at the time of the application, your participation does not infringe any third party’s IPRs. You are responsible for obtaining any and all necessary permissions from third parties to use their IPRs in your application. We reserve the right to disclose your identity to any third party claiming information, data and/or material disclosed by you as part of your application constitutes a violation of their IPRs, or their confidentiality/privacy rights.
You retain full and exclusive ownership of your information and owned intellectual property rights.
All costs and expenses incurred by the applicant in preparing its application will be borne by the applicant. There will be no recourse for the recovering of these costs, regardless of the outcome of the evaluation.
Please note that applications and supporting documents are to be submitted in English.
Applicants must inform us of any change to the application or the information thereof. We will decide how to handle such changes and inform you of our decision.
The terms and conditions of this call for proposals shall be governed by and construed in accordance with the laws of the state of Israel, without regard to its principles of conflict of laws. Any dispute arising under these terms and conditions shall be subject to the exclusive jurisdiction of the courts in Tel Aviv, Israel.